Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Enzhou Lu, Ilgiz Gareev, Chao Yuan, Yanchao Liang, Jingxian Sun, Xin Chen, Ozal Beylerli, Albert Sufianov, Shiguang Zhao & Guang Yang. (2022) The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma. Current Pharmaceutical Design 28:23, pages 1863-1869.
Crossref
Crossref
Anna K Nowak, Wee Loong Chin, Synat Keam & Alistair Cook. (2021) Immune checkpoint inhibitor therapy for malignant pleural mesothelioma. Lung Cancer 162, pages 162-168.
Crossref
Crossref
Jaewan Jeon, Sungmin Lee, Hyunwoo Kim, Hyunkoo Kang, HyeSook Youn, Sunmi Jo, BuHyun Youn & Hae Yu Kim. (2021) Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas. International Journal of Molecular Sciences 22:10, pages 5111.
Crossref
Crossref
Oladapo Yeku, Andrea L. Russo, Hang Lee & David Spriggs. (2020) A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma. Journal of Translational Medicine 18:1.
Crossref
Crossref
Max Lacour, Stefanie Hiltbrunner, Seok-Yun Lee, Alex Soltermann, Elisabeth Jane Rushing, Davide Soldini, Walter Weder & Alessandra Curioni-Fontecedro. (2019) Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non–small Cell Lung Cancer Recurrence. Clinical Lung Cancer 20:5, pages 391-396.
Crossref
Crossref
Martina Raudenska, Jan Balvan, Michaela Fojtu, Jaromir Gumulec & Michal Masarik. (2019) Unexpected therapeutic effects of cisplatin. Metallomics 11:7, pages 1182-1199.
Crossref
Crossref
Nathan B. Roberts, Aymen Alqazzaz, Jacqueline R. Hwang, Xiulan Qi, Achsah D. Keegan, Anthony J. Kim, Jeffrey A. Winkles & Graeme F. Woodworth. (2018) Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction. Journal of Neuro-Oncology 140:3, pages 497-507.
Crossref
Crossref
Jiacheng Ma, Annemieke Kavelaars, Patrick M. Dougherty & Cobi J. Heijnen. (2018) Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source. Cancer 124:11, pages 2289-2298.
Crossref
Crossref
Alberta Bergamo, Paul J. Dyson & Gianni Sava. (2018) The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions. Coordination Chemistry Reviews 360, pages 17-33.
Crossref
Crossref
Stanleyson V. Hato, Carl G. Figdor, Susumu Takahashi, Anja E. Pen, Altuna Halilovic, Kalijn F. Bol, Angela Vasaturo, Yukie Inoue, Nienke de Haas, Dagmar Verweij, Carla M.L. Van Herpen, Johannes H. Kaanders, Johan H.J.M. van Krieken, Hanneke W.M. Van Laarhoven, Gerrit K.J. Hooijer, Cornelis J.A. Punt, Akira Asai, I. Jolanda M. de Vries & W. Joost Lesterhuis. (2017) Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity. Oncotarget 8:33, pages 54434-54443.
Crossref
Crossref
Gaëlle Douchet & Sandrine Aspeslagh. (2017) Quelle place pour les associations de l’immunothérapie à la chimiothérapie ou de plusieurs immunothérapies ?. Bulletin du Cancer 104:5, pages 485-493.
Crossref
Crossref
Melanie Arul, April Camilla Roslani & Swee Hung Cheah. (2017) Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro. In Vitro Cellular & Developmental Biology - Animal 53:5, pages 435-447.
Crossref
Crossref
Dirk Theile. (2017) Under-Reported Aspects of Platinum Drug Pharmacology. Molecules 22:3, pages 382.
Crossref
Crossref
Venkatesh Krishnan, Jonathan S. Berek & Oliver Dorigo. (2017) Immunotherapy in ovarian cancer. Current Problems in Cancer 41:1, pages 48-63.
Crossref
Crossref
G. Coukos, J. Tanyi & L.E. Kandalaft. (2016) Opportunities in immunotherapy of ovarian cancer. Annals of Oncology 27, pages i11-i15.
Crossref
Crossref
Morena Antonilli, Hassan Rahimi, Valeria Visconti, Chiara Napoletano, Ilary Ruscito, Ilaria Zizzari, Salvatore Caponnetto, Giacomo Barchiesi, Roberta Iadarola, Luca Pierelli, Aurelia Rughetti, Filippo Bellati, Pierluigi Panici & Marianna Nuti. (2016) Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial. International Journal of Oncology.
Crossref
Crossref
Cariad Chester, Oliver Dorigo, Jonathan S Berek & Holbrook Kohrt. (2015) Immunotherapeutic approaches to ovarian cancer treatment. Journal for ImmunoTherapy of Cancer 3:1.
Crossref
Crossref
Christina Wefers, Laurens J. Lambert, Ruurd Torensma & Stanleyson V. Hato. (2015) Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence. Gynecologic Oncology 137:2, pages 335-342.
Crossref
Crossref
Laura Gatti, Giuliana Cassinelli, Nadia Zaffaroni, Cinzia Lanzi & Paola Perego. (2015) New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants. Drug Resistance Updates 20, pages 1-11.
Crossref
Crossref
Javier Hernández-Gil, Macarena Cobaleda-Siles, Aintzane Zabaleta, Luca Salassa, Javier Calvo & Juan C. Mareque-Rivas. (2015) An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects. Advanced Healthcare Materials 4:7, pages 1034-1042.
Crossref
Crossref
Wayne J Aston, Scott A Fisher, Andrea Khong, Clara Mok, Anna K Nowak, Richard A Lake & W Joost Lesterhuis. (2014) Combining chemotherapy and checkpoint blockade in thoracic cancer: how to proceed?. Lung Cancer Management 3:6, pages 443-457.
Crossref
Crossref
Emese Zsiros, Janos Tanyi, Klara Balint & Lana E. Kandalaft. (2014) Immunotherapy for ovarian cancer. Current Opinion in Oncology 26:5, pages 492-500.
Crossref
Crossref
L. A. Bogdanova, T. S. Morozkova, S. A. Amitina, D. G. Mazhukin, V. P. Nikolin, N. A. Popova & V. I. Kaledin. (2014) Dual Effects of Indoleamine 2,3-Dioxygenase Inhibitors on the Therapeutic Effects of Cyclophosphamide and Cycloplatam on Ehrlich Ascites Tumor in Mice. Bulletin of Experimental Biology and Medicine 157:4, pages 506-509.
Crossref
Crossref
Gerhard Hamilton. (2014) Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin. Cancers 6:3, pages 1487-1499.
Crossref
Crossref
Stanleyson V. Hato, Andrea Khong, I. Jolanda M. de Vries & W. Joost Lesterhuis. (2014) Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics. Clinical Cancer Research 20:11, pages 2831-2837.
Crossref
Crossref
W. Joost Lesterhuis, Anna K. Nowak & Richard A. Lake. 2013. Cancer Immunotherapy. Cancer Immunotherapy
395
414
.
Esdy N. Rozali, Stanleyson V. Hato, Bruce W. Robinson, Richard A. Lake & W. Joost Lesterhuis. (2012) Programmed Death Ligand 2 in Cancer-Induced Immune Suppression. Clinical and Developmental Immunology 2012, pages 1-8.
Crossref
Crossref